| Views | |
|---|---|
| Therapies with CCL25 require controlled release via microparticles to avoid strong inflammatory reactions | 119 |
| March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
|---|---|---|---|---|---|---|---|
| Therapies with CCL25 require controlled release via microparticles to avoid strong inflammatory reactions | 8 | 11 | 3 | 2 | 4 | 0 | 0 |
| Views | |
|---|---|
| 2021_Spinnen_etal.pdf | 65 |
